
Bill Pushes Legislation to Restore Medicare Funding for Cancer Treatments
A new bill, Cancer Patient Protection Act of 2013 (HR 1416), is aiming to restore Medicare reimbursements for anti-cancer drugs and biologicals to pre-sequester levels
A new bill,
After a recent hearing by the House Energy and Commerce Health Subcommittee, the
Our fight is not over, however. ACCC continues to educate other members of the House about the importance of this legislation. ACCC recently met with Representative Erik Paulsen’s office, who is one of the latest members to sign onto HR 1416. We are continuing to work to identify a champion in the Senate.
Read the full story here:
Newsletter
Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.